15 Results

People

  1. Kris
    Kris
  2. Ni
    Ni
  3. Riely
    Riely
  4. Yu
    Yu
  5. Drilon
    Drilon
  6. Li
    Li
  7. Arcila
    Arcila
  8. Hellmann
    Hellmann
  9. Jordan
    Jordan
  10. Offin
    Offin

Groups

  1. Biostatistics Service (15)
  2. Department of Medicine (15)
  3. Epidemiology and Biostatistics (15)
  4. Solid Tumor Oncology Division (15)
  5. Thoracic Oncology (15)
  6. GSK Faculty (11)
  7. Tow Center for Developmental Oncology (TCDO) (11)
  8. Human Oncology and Pathogenesis Program (10)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  10. Radiology, Department of (7)
  1. "Ai Ni"
  2. "Gregory Riely"
  3. "Helena Yu"
  4. "Mark Kris"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (7)
Groups
  1. Biostatistics Service (15)
  2. Department of Medicine (15)
  3. Epidemiology and Biostatistics (15)
  4. Solid Tumor Oncology Division (15)
  5. Thoracic Oncology (15)
  6. GSK Faculty (11)

More Groups

People
  1. Ai Ni (15)
  2. Gregory Riely (15)
  3. Helena Yu (15)
  4. Mark Kris (15)
  5. Maria Arcila (11)
  6. Marc Ladanyi (9)

More People

Years
  1. 2019 (5)
  2. 2018 (6)
  3. 2017 (2)
  4. 2016 (2)
Publications
  1. Journal of Clinical Oncology (6)
  2. Clinical Cancer Research (3)
  3. Cancer (2)
  4. Cancer Discovery (1)
  5. Cold Spring Harbor Molecular Case Studies (1)
  6. JNCI: Journal of the National Cancer Institute (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (4)
  3. Wiley Blackwell (2)
  4. Cold Spring Harbor Laboratory Press (1)
  5. Elsevier Inc. (1)
  6. Oxford University Press (1)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
    Journal Article

    Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • A phase 1/2 study of osimertinib and bevacizumab as initial treatment for patients with metastatic EGFR-mutant lung cancers
    Meeting Abstract

    Yu, H. A.; Kim, R.; Makhnin, A.; Ahn, L. S. H.; Ni, A.; Hayes, S. A.; Young, R. J.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers
    Journal Article

    Sabari, J. K.; Offin, M.; Stephens, D.; Ni, A.; Lee, A.; Pavlakis, N.; Clarke, S.; Diakos, C. I.; Datta, S.; Tandon, N.; more...
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • Exceptional responders with invasive mucinous adenocarcinomas: A phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
    Journal Article

    Drilon, A.; Schoenfeld, A. J.; Arbour, K. C.; Litvak, A.; Ni, A.; Montecalvo, J.; Yu, H. A.; Panora, E.; Ahn, L.; Kennedy, M.; more...
    Cold Spring Harbor Molecular Case Studies (2019)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of EGFR-tyrosine kinase inhibitors in patients with EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez-Vega, F.; Li, B. T.; Drilon, A.; Kris, M. G.; Rudin, C. M.; Schultz, N.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers
    Meeting Abstract

    Offin, M. D.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez Vega, F.; Kris, M. G.; Rudin, C. M.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of brain metastases and outcomes in patients with HER2-, KRAS-, and EGFR-mutant lung cancers
    Meeting Abstract

    Kris, M. G.; Offin, M. D.; Feldman, D. L.; Ni, A.; Lai, W. C. V.; Arbour, K. C.; Daras, M.; Pentsova, E.; DeAngelis, L. M.; Beal, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • MET exon 14-altered lung cancers: Central nervous system (CNS) metastases and patterns of CNS progression on MET inhibition
    Meeting Abstract

    Offin, M.; Dienstag, J.; Wilkins, O.; Sabari, J.; Ni, A.; Feldman, D.; Van Voorthuysen, M.; Suzawa, K.; Yu, H.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent alterations in EGFR-mutant lung cancers associated with resistance to EGFR kinase inhibitors and characterization of MTOR as a mediator of resistance
    Journal Article

    Yu, H. A.; Suzawa, K.; Jordan, E.; Zehir, A.; Ni, A.; Kim, R.; Kris, M. G.; Hellmann, M. D.; Li, B. T.; Somwar, R.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Jordan, E.; Kim, H. R.; Dienstag, J.; Yu, H. A.; Sanchez-Vega, F.; Lito, P.; Berger, M.; Solit, D. B.; Hellmann, M.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save